Loading…
Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone
The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition...
Saved in:
Published in: | Cancer science 1993-05, Vol.84 (5), p.481-484 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783 |
---|---|
cites | cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783 |
container_end_page | 484 |
container_issue | 5 |
container_start_page | 481 |
container_title | Cancer science |
container_volume | 84 |
creator | Hirose, Masao Akagi, Keisuke Hasegawa, Ryohei Satoh, Toshio Nihro, Yasunori Miki, Tokutaro Sugimura, Takashi Ito, Nobuyuki |
description | The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis. |
doi_str_mv | 10.1111/j.1349-7006.1993.tb00162.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5919179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2399199500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</originalsourceid><addsrcrecordid>eNqVUctuEzEUtRCopIVPQBoBy8zgxzy7QIqiQioVdQGsELI8YztxNLFTewKZrvoJfEv5o34Jd5QhwBJLV9fWOef62AehlwQnBNabdUJYWsUFxnlCqoolXY0xyWmyf4QmR-gxmuCK4DjDGX6KTkNYA6nAOT1BJyWjIGAT9PNj551dRpd2ZWrTGWcjpyP6cPdjtjHWQc-hNqpb9a00294b6b6004EgztnD3f2wvYeT_Go2Ropb1yo4GSt3jZLRh10nlsqqYEIkrIwWais61wjfwPDfQN1HBDTXUAu171vodMqmGfTOm8Pdq156d7MDlVXP0BMt2qCej_0MfX538Wm-iK-u31_OZ1dxkzFGYqaZKKgohMZYy7JWlSIlUVITCl-EKZN52ghWZwUTKa41TZWSGc6lSHUpi5KdobeHudtdvVGyUbbzouVb8CR8z50w_F_EmhVfum88q0hFigoGvBoHDN5V6Pja7bwFz5yyCkhVhjGwzg-sxrsQvNLHGwjmQ958zYdQ-RAqH_LmY958D-IXf3s8SseAAX894iI0otVe2MaEIy0t8rIs6J-nfjet6v_DAJ_PLtKSsF-tBNdt</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2399199500</pqid></control><display><type>article</type><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><source>PubMed Central Free</source><source>ProQuest - Publicly Available Content Database</source><creator>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</creator><creatorcontrib>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</creatorcontrib><description>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</description><identifier>ISSN: 0910-5050</identifier><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>EISSN: 1876-4673</identifier><identifier>DOI: 10.1111/j.1349-7006.1993.tb00162.x</identifier><identifier>PMID: 8320163</identifier><identifier>CODEN: GANNA2</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Anticarcinogenic Agents - pharmacology ; Antimutagenic Agents - pharmacology ; Antioxidant ; Antioxidants - pharmacology ; Anti‐mutagenesis ; Ascorbic Acid - pharmacology ; Biological and medical sciences ; Body Weight - drug effects ; Carcinogenesis, carcinogens and anticarcinogens ; Chemical agents ; Chemoprevention ; Hepatocarcinogenesis ; Heterocyclic amine ; Hydroquinones - pharmacology ; Imidazole ; Imidazoles - toxicity ; Liver Neoplasms, Experimental - chemically induced ; Liver Neoplasms, Experimental - prevention & control ; Male ; Medical sciences ; Mutagenesis ; Mutagens - toxicity ; Rapid Communication ; Rats ; Rats, Inbred F344 ; Revertants ; Salmonella ; Tumors</subject><ispartof>Cancer science, 1993-05, Vol.84 (5), p.481-484</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright John Wiley & Sons, Inc. May 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</citedby><cites>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2399199500/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2399199500?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4768872$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8320163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirose, Masao</creatorcontrib><creatorcontrib>Akagi, Keisuke</creatorcontrib><creatorcontrib>Hasegawa, Ryohei</creatorcontrib><creatorcontrib>Satoh, Toshio</creatorcontrib><creatorcontrib>Nihro, Yasunori</creatorcontrib><creatorcontrib>Miki, Tokutaro</creatorcontrib><creatorcontrib>Sugimura, Takashi</creatorcontrib><creatorcontrib>Ito, Nobuyuki</creatorcontrib><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><title>Cancer science</title><addtitle>Jpn J Cancer Res</addtitle><description>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</description><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Antimutagenic Agents - pharmacology</subject><subject>Antioxidant</subject><subject>Antioxidants - pharmacology</subject><subject>Anti‐mutagenesis</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Chemical agents</subject><subject>Chemoprevention</subject><subject>Hepatocarcinogenesis</subject><subject>Heterocyclic amine</subject><subject>Hydroquinones - pharmacology</subject><subject>Imidazole</subject><subject>Imidazoles - toxicity</subject><subject>Liver Neoplasms, Experimental - chemically induced</subject><subject>Liver Neoplasms, Experimental - prevention & control</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mutagenesis</subject><subject>Mutagens - toxicity</subject><subject>Rapid Communication</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Revertants</subject><subject>Salmonella</subject><subject>Tumors</subject><issn>0910-5050</issn><issn>1347-9032</issn><issn>1349-7006</issn><issn>1876-4673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqVUctuEzEUtRCopIVPQBoBy8zgxzy7QIqiQioVdQGsELI8YztxNLFTewKZrvoJfEv5o34Jd5QhwBJLV9fWOef62AehlwQnBNabdUJYWsUFxnlCqoolXY0xyWmyf4QmR-gxmuCK4DjDGX6KTkNYA6nAOT1BJyWjIGAT9PNj551dRpd2ZWrTGWcjpyP6cPdjtjHWQc-hNqpb9a00294b6b6004EgztnD3f2wvYeT_Go2Ropb1yo4GSt3jZLRh10nlsqqYEIkrIwWais61wjfwPDfQN1HBDTXUAu171vodMqmGfTOm8Pdq156d7MDlVXP0BMt2qCej_0MfX538Wm-iK-u31_OZ1dxkzFGYqaZKKgohMZYy7JWlSIlUVITCl-EKZN52ghWZwUTKa41TZWSGc6lSHUpi5KdobeHudtdvVGyUbbzouVb8CR8z50w_F_EmhVfum88q0hFigoGvBoHDN5V6Pja7bwFz5yyCkhVhjGwzg-sxrsQvNLHGwjmQ958zYdQ-RAqH_LmY958D-IXf3s8SseAAX894iI0otVe2MaEIy0t8rIs6J-nfjet6v_DAJ_PLtKSsF-tBNdt</recordid><startdate>199305</startdate><enddate>199305</enddate><creator>Hirose, Masao</creator><creator>Akagi, Keisuke</creator><creator>Hasegawa, Ryohei</creator><creator>Satoh, Toshio</creator><creator>Nihro, Yasunori</creator><creator>Miki, Tokutaro</creator><creator>Sugimura, Takashi</creator><creator>Ito, Nobuyuki</creator><general>Blackwell Publishing Ltd</general><general>Japanese Cancer Association</general><general>John Wiley & Sons, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>199305</creationdate><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><author>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Antimutagenic Agents - pharmacology</topic><topic>Antioxidant</topic><topic>Antioxidants - pharmacology</topic><topic>Anti‐mutagenesis</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Chemical agents</topic><topic>Chemoprevention</topic><topic>Hepatocarcinogenesis</topic><topic>Heterocyclic amine</topic><topic>Hydroquinones - pharmacology</topic><topic>Imidazole</topic><topic>Imidazoles - toxicity</topic><topic>Liver Neoplasms, Experimental - chemically induced</topic><topic>Liver Neoplasms, Experimental - prevention & control</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mutagenesis</topic><topic>Mutagens - toxicity</topic><topic>Rapid Communication</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Revertants</topic><topic>Salmonella</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirose, Masao</creatorcontrib><creatorcontrib>Akagi, Keisuke</creatorcontrib><creatorcontrib>Hasegawa, Ryohei</creatorcontrib><creatorcontrib>Satoh, Toshio</creatorcontrib><creatorcontrib>Nihro, Yasunori</creatorcontrib><creatorcontrib>Miki, Tokutaro</creatorcontrib><creatorcontrib>Sugimura, Takashi</creatorcontrib><creatorcontrib>Ito, Nobuyuki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirose, Masao</au><au>Akagi, Keisuke</au><au>Hasegawa, Ryohei</au><au>Satoh, Toshio</au><au>Nihro, Yasunori</au><au>Miki, Tokutaro</au><au>Sugimura, Takashi</au><au>Ito, Nobuyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</atitle><jtitle>Cancer science</jtitle><addtitle>Jpn J Cancer Res</addtitle><date>1993-05</date><risdate>1993</risdate><volume>84</volume><issue>5</issue><spage>481</spage><epage>484</epage><pages>481-484</pages><issn>0910-5050</issn><issn>1347-9032</issn><eissn>1349-7006</eissn><eissn>1876-4673</eissn><coden>GANNA2</coden><abstract>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8320163</pmid><doi>10.1111/j.1349-7006.1993.tb00162.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0910-5050 |
ispartof | Cancer science, 1993-05, Vol.84 (5), p.481-484 |
issn | 0910-5050 1347-9032 1349-7006 1876-4673 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5919179 |
source | PubMed Central Free; ProQuest - Publicly Available Content Database |
subjects | Animals Anticarcinogenic Agents - pharmacology Antimutagenic Agents - pharmacology Antioxidant Antioxidants - pharmacology Anti‐mutagenesis Ascorbic Acid - pharmacology Biological and medical sciences Body Weight - drug effects Carcinogenesis, carcinogens and anticarcinogens Chemical agents Chemoprevention Hepatocarcinogenesis Heterocyclic amine Hydroquinones - pharmacology Imidazole Imidazoles - toxicity Liver Neoplasms, Experimental - chemically induced Liver Neoplasms, Experimental - prevention & control Male Medical sciences Mutagenesis Mutagens - toxicity Rapid Communication Rats Rats, Inbred F344 Revertants Salmonella Tumors |
title | Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A05%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strong%20Inhibition%20of%202%E2%80%90Amino%E2%80%906%E2%80%90methyldipyrido%5Bl,2%E2%80%90a:3%E2%80%B2,2%E2%80%B2%E2%80%90d%5Dimidazole%E2%80%90induced%20Mutagenesis%20and%20Hepatocarcinogenesis%20by%201%E2%80%90O%E2%80%90Hexyl%E2%80%902,3,5%E2%80%90trimethylhydroquinone&rft.jtitle=Cancer%20science&rft.au=Hirose,%20Masao&rft.date=1993-05&rft.volume=84&rft.issue=5&rft.spage=481&rft.epage=484&rft.pages=481-484&rft.issn=0910-5050&rft.eissn=1349-7006&rft.coden=GANNA2&rft_id=info:doi/10.1111/j.1349-7006.1993.tb00162.x&rft_dat=%3Cproquest_pubme%3E2399199500%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2399199500&rft_id=info:pmid/8320163&rfr_iscdi=true |